Hence, PRL and bone metabolism markers should be examined to monitor the bone health status of schizophrenia patients, especially those who are on antipsychotic drug regimens for an extended period, in order to better prevent osteoporosis and fractures. The gene discussed is PRL; the disease is osteoporosis.